A Phase II Study of SKB571 in Patients With Lung Cancer

Clinical trial NCT07230405 · RECRUITING

Trial details

NCT number: NCT07230405
Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer (Non-Small Cell)

Start date: 2026-01-19
Primary completion: 2028-01-19
Enrollment: 295

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.